3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroendocrine Tumors
1
Interventions
pembrolizumab
2
ribociclib
1
napabucasin
1
epacadostat
1
amrubicin
1
Sunitinib
1
Plicamycin
1
Paclitaxel
1
Nivolumab
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Thymus Neoplasms
×
177Lu-octreotide, DOTA(0)-Tyr(3)-
×
Clear all
No trials found.